Great Tree Pharmacy - Public Comps and Valuation Multiples

Great Tree Pharmacy Overview

About Great Tree Pharmacy

Great Tree Pharmacy Co Ltd is engaged in the management and trade of various drugs, health products, goods for mothers and babies, and cosmetics products. The firm also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, the company is also an agency for domestic and foreign healthcare products sold in clinics, outpatient centers, and medical communities.

Founded

2001

HQ

Employees

2.3K+

Website

greattree.com.tw

Sectors

Pharmacies

Financials

LTM Revenue $609M

LTM EBITDA $54.5M

EV

$701M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Great Tree Pharmacy Financials

As of September 2025, Great Tree Pharmacy reported last 12-month revenue of $609M and EBITDA of $54.5M.

In the same period, Great Tree Pharmacy generated $165M in LTM gross profit and $23.5M in net income.

See Great Tree Pharmacy valuation multiples based on analyst estimates

Great Tree Pharmacy P&L

In the most recent fiscal year, Great Tree Pharmacy reported revenue of $562M and EBITDA of $55.5M.

Great Tree Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Great Tree Pharmacy valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$609M	XXX	$562M	XXX	XXX	XXX
Gross Profit	$165M	XXX	$158M	XXX	XXX	XXX
Gross Margin	27%	XXX	28%	XXX	XXX	XXX
EBITDA	$54.5M	XXX	$55.5M	XXX	XXX	XXX
EBITDA Margin	9%	XXX	10%	XXX	XXX	XXX
EBIT	$28.1M	XXX	$26.1M	XXX	XXX	XXX
EBIT Margin	5%	XXX	5%	XXX	XXX	XXX
Net Profit	$23.5M	XXX	$22.2M	XXX	XXX	XXX
Net Margin	4%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Great Tree Pharmacy including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $609M. EBITDA for the last twelve months was $54.5M. In the most recent fiscal year, Great Tree Pharmacy achieved $562M in revenue and $55.5M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$609M	Analyst estimates available to subscribers	$562M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$165M	Analyst estimates available to subscribers	$158M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	27.2% gross margin	Analyst estimates available to subscribers	28.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$54.5M	Analyst estimates available to subscribers	$55.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	8.9% EBITDA margin	Analyst estimates available to subscribers	9.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$28.1M	Analyst estimates available to subscribers	$26.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	4.6% EBIT margin	Analyst estimates available to subscribers	4.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$23.5M	Analyst estimates available to subscribers	$22.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	3.9% net profit margin	Analyst estimates available to subscribers	3.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Great Tree Pharmacy

This financial data table provides comprehensive performance metrics for Great Tree Pharmacy, a company based in Taiwan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Great Tree Pharmacy generated $609M in revenue over the last twelve months.
The company achieved $54.5M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $165M.
Net income over the last twelve months reached $23.5M.

Fiscal Year Performance

In the most recent fiscal year, Great Tree Pharmacy reported $562M in total revenue.
Fiscal year EBITDA was $55.5M.
The company maintained a gross profit margin of 28.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.9%.
Net profit margin reached 3.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Great Tree Pharmacy. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Great Tree Pharmacy Stock Performance

Great Tree Pharmacy has current market cap of TWD 17.4B (or $565M), and EV of TWD 21.5B (or $701M).

Market Cap Evolution

Great Tree Pharmacy Stock Data

As of October 17, 2025, Great Tree Pharmacy's stock price is TWD 116 (or $4).

See Great Tree Pharmacy trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$701M	$565M	XXX	XXX	XXX	XXX	$0.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Great Tree Pharmacy Valuation Multiples

Great Tree Pharmacy's trades at 1.2x EV/Revenue multiple, and 12.6x EV/EBITDA.

See valuation multiples for Great Tree Pharmacy and 15K+ public comps

Great Tree Pharmacy Financial Valuation Multiples

As of October 17, 2025, Great Tree Pharmacy has market cap of $565M and EV of $701M.

Equity research analysts estimate Great Tree Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Great Tree Pharmacy has a P/E ratio of 24.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$565M	XXX	$565M	XXX	XXX	XXX
EV (current)	$701M	XXX	$701M	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	1.2x	XXX	XXX	XXX
EV/EBITDA	12.9x	XXX	12.6x	XXX	XXX	XXX
EV/EBIT	25.0x	XXX	26.9x	XXX	XXX	XXX
EV/Gross Profit	4.2x	XXX	n/a	XXX	XXX	XXX
P/E	24.1x	XXX	25.5x	XXX	XXX	XXX
EV/FCF	34.3x	XXX	28.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Great Tree Pharmacy Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Great Tree Pharmacy Margins & Growth Rates

Great Tree Pharmacy's last 12 month revenue growth is 9%

Great Tree Pharmacy's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Great Tree Pharmacy's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Great Tree Pharmacy's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Great Tree Pharmacy and other 15K+ public comps

Great Tree Pharmacy Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	10%	XXX	XXX	XXX
EBITDA Margin	9%	XXX	10%	XXX	XXX	XXX
EBITDA Growth	5%	XXX	3%	XXX	XXX	XXX
Rule of 40	19%	XXX	19%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	32%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	20%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	23%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial